tradingkey.logo
tradingkey.logo
Search

Elicio Therapeutics Inc

ELTX
Add to Watchlist
1.915USD
+0.005+0.26%
Market hours 09/22, 15:50ET
41.94MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.26%

5 Days

-4.25%

1 Month

-37.01%

6 Months

-82.35%

Year to Date

-75.94%

1 Year

-83.08%

Key Figures

1.930Open
1.925High
22.50KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
1.910Prev. Close
1.820Low
42.19KTurnover
LossP/E Static
5.28P/B
0.00%Div Yield TTM
-158.11%ROA
16.00052wk High
0.05Volume Ratio
-51.90MNet Profit
21.90MShares
-2.3679EPS TTM
--Beta
-1076.34%ROE
1.70552wk Low
5.50%Amplitude
100.00%Gross Margin
41.94MMarket Cap
0.26Reward/Risk
8.90%Risk Rate
More news coming soon, stay tuned...

Elicio Therapeutics Inc's Score

-0.18vs previous score
Forecast8.00
Financial Health6.78
Technical6.26
Valuation Dimensions6.74
Institutional Confidence3.00
Risk Assessment2.40

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
20.000Target Price
+958.20%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy11100000
Buy22222222
Hold11100000
Sell00000000
Strong Sell00000000

Elicio Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.43/-0.54
Revenue / Forecast
--/0.00

Elicio Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolELTX
Number of employees32
CountryUnited States of America

Ownership

ShareholdersProportion
GKCC, LLC28.38%
Knoll Capital Management, LLC3.31%
Vanguard Capital Management, LLC2.72%
Actyus Private Equity SGIIC, S.A.1.41%
Shareholder TypesProportion
Corporation28.96%
Investment Advisor7.57%
Hedge Fund4.83%
Investment Advisor/Hedge Fund2.22%

FAQs

What is the current price of Elicio Therapeutics Inc (ELTX)?

The current price of Elicio Therapeutics Inc (ELTX) is 1.91.

What is the symbol of Elicio Therapeutics Inc?

The ticker symbol of Elicio Therapeutics Inc is ELTX.

What is the 52-week high of Elicio Therapeutics Inc?

The 52-week high of Elicio Therapeutics Inc is 16.00.

What is the 52-week low of Elicio Therapeutics Inc?

The 52-week low of Elicio Therapeutics Inc is 1.71.

What is the market capitalization of Elicio Therapeutics Inc?

The market capitalization of Elicio Therapeutics Inc is 42.05M.

Is Elicio Therapeutics Inc (ELTX) currently rated as Buy, Hold, or Sell?

According to analysts, Elicio Therapeutics Inc (ELTX) has an overall rating of Buy, with a price target of 20.00.

What is the Earnings Per Share (EPS TTM) of Elicio Therapeutics Inc (ELTX)?

The Earnings Per Share (EPS TTM) of Elicio Therapeutics Inc (ELTX) is -2.37.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.